The COVID-19 pandemic has brought fast moving, changing variables placing extraordinary strains and uncertainty on society as whole. The changes in primary and secondary care globally have and will continue to affect future pharmaceutical forecasts for in-market and new product launches. High levels of unpredictability…
14th September 2020Read More
J+D Forecasting strike the balance between simplicity and complexity when modelling for the liquid tumour market12th August 2020
J+D’s approach and the model has given the team greater confidence in the outputs and subsequent decisions they will have to make in taking the product forward.
23rd July 2020Read More
One of the world’s first global biotechnology companies a leader, in innovative scientific research in neurological diseases approached J+D Forecasting with a set of forecasting challenges.
21st July 2020Read More
Here we offer insight into how you can improve efficiencies in your long range strategic planning by moving to cloud-based software solutions.
20th July 2020Read More
Here we offer insight into the best practises for visualising your forecast, from thinking about your audience to interacting with data.
18th June 2020Read More
When you are creating a sales-based forecast there can be a wide range of sophisticated forecasting methodologies available to you.
15th June 2020Read More
An article written by David James, IPI - International Pharmaceutical Industry
17th April 2019Read More
Contact us for a consultation Find more J+D Forecasting insights 1 – All Change Consider the stability of the market when deciding on the methodology. Patient flow models are accurate and provide a great deal of insight, however, they’re only really necessary when there is…